Contact Us
Email Us: Customer Service
Phone (US): 703-778-3080
Fax: 703-778-3081
-
Pay Invoice
Follow Us!
Latest Blogs
- How Market Research Supercharges Laboratory Diagnostics Go-To-Market Strategies April 24, 2024
- 4 Key Components to a Winning Go-To-Market Strategy April 24, 2024
- Immunoassays: A $27 Billion Market of Intrigue and Opportunity April 12, 2024
- IVD in Egypt: $440 Million Market Lead by Immunodiagnostic and Molecular Diagnostic Growth April 11, 2024
- Momentum in Multiplex Testing for IVD April 1, 2024
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group
Thermo and Qiagen Merger Changes Molecular Diagnostics
As Kalorama publishes its latest update in molecular diagnostics, finding a 13 billion-dollar market, a major merger is set to change things. Here’s what to expect. The market picture for molecular diagnostics had remained stable over the years. While there are scores of molecular diagnostic companies, and an explosion of PCR test kit companies during […]
COVID-19 Testing Increases Value of Global Molecular Diagnostics Market
As the COVID-19 crisis surfaced in the United States, molecular diagnostic manufacturers went to work with new RT-PCR testing kits. The worldwide demand for COVID tests has materialized rapidly from zero and already on course become a 1.3 billion-dollar market in the first half of 2020. There have been hundreds of tests on the market […]
Could COVID-19 Influence LDT Regulation?
Lab-developed tests were controversial before the COVID-19 pandemic, and there was attempts at regulating them more in the United States. Then came a massive infectious disease threat for which lab developed tests were essential. The sudden onset of a disease for which there were no existing test products, so labs had to develop their own. […]
As COVID Testing Expands Rapidly, Recommendations and Consenus Taking Shape
The landscape of COVID-19 testing has been rapidly evolving. New products and services are continually being introduced, and regulatory approvals have been growing and expanding to include more types of tests, samples, and sample collection methods. With the sudden global demand and governments loosening requirements during the crisis, there has been an unprecedented flood of […]
COVID-19 Has Small Negative Impact on Important Companion Diagnostic Testing, Report Finds
Companion diagnostics are rising to the forefront of pharmaceutical development and treatment. Companion diagnostics increase the probability of clinical success by identifying patients with the presence of biomarkers or disease-specific therapeutic targets that can dramatically improve outcomes. The COVID-19 pandemic has gripped the world and continues to be a major area of research and development […]
Chagas: Opportunity for Testing Companies as US Army, CDC Get Involved
In Kalorama Information’s Emerging Infections Testing report (https://kaloramainformation.com/product/emerging-infectious-disease-diagnostics-markets-and-trends/) , we discussed Chagas. Chagas disease is named after the Brazilian physician Carlos Ribeiro Justiniano Chagas, who discovered the disease in 1909. Chagas disease (Trypanosoma cruzi, known as kissing bugs) is also referred to as American trypanosomiasis. It is endemic throughout Mexico, and Central and South America, and is caused […]
Six Other Respiratory Conditions Healthcare Systems are Watching
The fast spread of COVID-19, a respiratory condition, has healthcare systems focused on other diseases that could spread using the same method. Kalorama Information’s Emerging Infectious Disease Diagnostics report: (https://kaloramainformation.com/product/emerging-infectious-disease-diagnostics-markets-and-trends/) details multiple types of viruses that are being tracked worldwide, many that have jumped from developing nations to developed ones. These are some of the […]
Coagulation Tests Find Use in COVID-19, New Anticoagulants
Coagulation is a complex process in which multiple enzymes and proteins regulate blood flow and clot formation. Coagulation (clot formation), fibrinolysis and platelet aggregation are a part of this process. Fibrinolysis refers to the breakup of blood clots. It is a normal body process that keeps naturally occurring blood clots from growing and causing problems. Anticoagulant drugs help prevent blood platelets from sticking or clumping together, reducing the likelihood that arteries will be blocked by a clot, leading to a stroke or heart attack.
Drug Discovery Outsourcing – COVID-19 has Mixed Effect
Drug discovery is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will actually yield products that achieve regulatory approval by the U.S. Food & Drug Administration (FDA) or other global regulatory agencies. The average drug can take 10+ years to progress from the discovery phase to the clinic, […]
Cell Therapy Market Reaches 3.8 BN; Cancer Treatments Dominate and COVID-19 Applications Explored
Cell therapy involves the modification of human cell which are used to replace or repair damaged tissues or cells. Two areas with growing development and commercialization include chimeric antigen receptor (CAR)-T therapies and stem cell therapies. According to a recent report from Kalorama Information, the global market for cell and gene therapy in 2020 is […]